FROM COMMON TO RARE:
ENHANCING PATIENT OUTCOME THROUGH A MULTIDISCIPLINARY TEAM
HOTEL HILTON BEOGRAD
September 18 - 19, 2025
ORGANIZERS
University Clinical Center of Serbia
Center for Medical Biochemistry
Serbian Society for Clinical Laboratory
Medicine and Science (SCLM)
UNDER THE AUSPICES
Dear Colleagues, Dear Friends,
It is my great pleasure and an immense honour to welcome you to SERBIS 2025 entitled “FROM COMMON TO RARE: Enhancing Patient Outcome Through a Multidisciplinary Team.”
In today’s evolving medical landscape, collaboration across specialties has become more vital than ever. From the most frequently encountered conditions to the rarest and most complex cases, the role of a cohesive, multidisciplinary team is at the heart of improving patient outcomes.
This congress brings together experts, clinicians, researchers, and allied health professionals to share insights, evidence-based strategies, and innovative approaches that highlight the power of teamwork in clinical practice. Over the course of the program, we will explore diverse topics, ranging from common clinical challenges to rare disease management—always with a focus on integrated care.
Whether you are here to present, learn, or connect, we hope this congress inspires new ideas, fosters meaningful collaboration, and reinforces our shared commitment to patient-centered care.
We look forward to a dynamic and enriching experience together.
Thank you for joining us.
Welcome to Serbia.
Welcome to Belgrade.
Welcome to SERBIS 2025.
SERBIS directors
Sanja Stankovic
Milika Asanin
SCIENTIFIC COMMITTEE
Khosrow ADELI,
Canada
Milika ASANIN,
Serbia
Sergio BERNARDINI,
Italy
Andrija BOGDANOVIC,
Serbia
Raffaele BUGIARDINI,
Italy
Edina CENKO,
Italy
Kyriakos DIMITRIADIS,
Greece
Alfredo R. GALASSI,
Italy
Emeline GERNEZ,
France
Guillaume GRZYCH,
France
Mirza DILIC,
Bosnia and Herzegovina
Bojan JOVANOVIC,
Serbia
Beata LIPSKA-ZIĘTKIEWICZ,
Poland
Adrian LLERENA,
Spain
Daphne MERKUS,
The Netherlands/Germany
Milija MIJAJLOVIC,
Serbia
Tamara MILOVANOVIC,
Serbia
Radomir NAUMOVIC,
Serbia
Elmir OMEROVIC,
Sweeden
Teresa PADRÓ,
Spain
Martina PAVLETIC,
Croatia
Italo PORTO,
Italy
Milan RADOVIC,
Serbia
Laurent RIOU,
France
Arsen RISTIC,
Serbia
Vincent SAPIN,
France
Aleksandra SOKIC-MILUTINOVIC,
Serbia
Goran STANKOVIC,
Serbia
Sanja STANKOVIC,
Serbia
Maja STOJANOVIC,
Serbia
Zorana VASILJEVIC-POKRAJCIC,
Serbia
Marija ZDRAVKOVIC,
Serbia
Aleksandra ZUROWSKA,
Poland
LOCAL ORGANIZING COMMITTEE
Sanja STANKOVIĆ
Olja GABRIĆ
Daniela BARTOLOVIĆ
Emina ČOLAK
Anica DJORDJEVIĆ
Jelica DJORDJEVIĆ
Jasna BJELANOVIĆ
Mirjana MILIVOJEVIĆ
Radmila OBRENOVIĆ
Tatjana VODNIK
TECHNICAL ORGANIZER
TCA travel agency
Ms. Radmila KOVAČEVIĆ
Ms. Katarina KOVAČEVIĆ
Tel.:
+381-11-3238-514
+381-11-3238-705
Mobile:
+381-063-300-719
E-mail:
beotel@tca.co.rs
Programme
Serbian Biomarker Symposium (SERBIS) 2025
FROM COMMON TO RARE: ENHANCING PATIENT OUTCOME THROUGH A MULTIDISCIPLINARY TEAM
Hotel Hilton Belgrade, Belgrade (SERBIA)
September 18-19, 2025
Day 1
THURSDAY, September 18th, 2025
08:00-09:00
Registration
Session 1
IMPLEMENTING BIOMARKERS IN CLINICAL PRACTICE: THE PATH TO IMPROVED PATIENT OUTCOMES AND VALUE-BASED HEALTHCARE
Chairs: Aleksandra SOKIC-MILUTINOVIC, Tamara MILOVANOVIC
09:00-09:20
Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease
Aleksandra SOKIC-MILUTINOVIC, SERBIA
09:20-09:40
Unveiling Chronic Liver Disease: The Role of Emerging Biomarkers
Tamara MILOVANOVIC, SERBIA
09:40-10:00
Integrated GAAD in Hepatocellular Carcinoma: A Step Toward Precision Oncology
Sanja STANKOVIC/Djordje KRALJ, SERBIA
10:00-10:30
Discussion
Chairs: Vincent SAPIN, Bojan JOVANOVIC
10:30-10:50
Traumatic Brain Injury: Clinical Perspectives and Management Approaches
Bojan JOVANOVIC, SERBIA
10:50-11:10
Current Trends in Biomarkers for Mild TBI
Vincent SAPIN, FRANCE
11:10-11:30
Strategies for Introducing Blood Biomarkers for Mild TBI in the Emergency Department
Martina PAVLETIC, CROATIA
11:30-12:00
Discussion
PLENARY LECTURES
Chair: Sergio Bernardini, ITALY
12:50-13:20
Pharmacogenetics in Clinical Decision-Making
Adrian LLERENA, SPAIN
13:20-13:50
Pediatric Laboratory Medicine: Insights and Innovations from the CALIPER Study
Khosrow ADELI, CANADA
14:15-15:00
Lunch & Networking
Session 2
CORONARY ARTERY DISEASE: EXPANDING THE HORIZONS OF CORONARY DIAGNOSTICS AND THERAPY
Chairs: Goran STANKOVIC, Marija ZDRAVKOVIC
15:00-15:20
A Glimpse into the Future of Complex Coronary Chronic Total Occlusion Revascularization
Alfredo R. GALASSI, ITALY
15:20-15:40
In-Stent Thrombosis and Thrombophilia: Almost Nobody Thinks About That, Even in the Most Prestigious PCI Centers
Mirza DILIC, BOSNIA AND HERZEGOVINA
15:40-16:00
Optimization of Coronary PCI: Intravascular Imaging vs Coronary Physiology
Italo PORTO, ITALY
16:00-16:20
Diagnostic and Prognostic AI-Driven Improvements in SPECT Myocardial Perfusion Imaging
Laurent RIOU, FRANCE
16:20-16:40
Biomarkers in Takotsubo Syndrome
Elmir OMEROVIC, SWEDEN
16:40-17:00
Epicardial Fat, Obesity, and CAD – Can We Untie the Knot?
Marija ZDRAVKOVIC, SERBIA
17:00-18:00
Discussion
Day 2
FRIDAY, September 19th, 2025
08:00-09:00
Registration
Session 3
LIPOPROTEINS AND OXIDATIVE STRESS: EMERGING INSIGHTS INTO CARDIOVASCULAR RISK
Chairs: Daphne MERKUS, Teresa PADRÓ
09:00-09:20
Pathophysiological Insights into Chronic Coronary Artery Disease and Hypertension: The Role of Homocysteine
Zorana VASILJEVIC POKRAJCIC, SERBIA
09:20-09:40
Oxidative Stress and Coronary Microvascular Disease
Daphne MERKUS, THE NETHERLANDS/GERMANY
09:40-10:00
High-Density Lipoproteins in Acute Coronary Syndromes: A Story Beyond Cholesterol
Teresa PADRÓ, SPAIN
10:00-10:20
Discussion
Chairs: Edina CENKO, Sanja STANKOVIC
10:20-10:40
Lp(a)-Associated Cardiovascular Risk & High-Risk Populations
Edina CENKO, ITALY
10:40-11:00
Lp(a) and Aortic Stenosis: Practical Insights
Kyriakos DIMITRIADIS, GREECE
11:00-11:20
Demystifying Lp(a) Testing: Bridging the Lab Bench and the Clinic
Sanja STANKOVIC, SERBIA
11:00-11:40
Discussion
PLENARY LECTURES
Chair: Khosrow ADELI, CANADA
13:30-14:00
Progress in Reducing Inequalities and Disparities in Cardiovascular Health: The Lancet Regional Health Commission–Europe Perspective
Raffaele BUGIARDINI, ITALY
14:00-14:30
The Role of Volatilomics in Modern Medicine: Clinical Applications and Future Prospects
Sergio BERNARDINI, ITALY
14:30-15:15
Lunch & Networking
Session 4
RARE DISEASES in FOCUS: A CLIN-LAB NEXUS
Chairs: Arsen RISTIC, Radomir NAUMOVIC
15:35-15:45
Early Clinical Presentation and Diagnosis of Patients with aHUS
Milan RADOVIC, SERBIA
15:45-15:55
Understanding aHUS: Primary vs. Secondary Forms
Radomir NAUMOVIC, SERBIA
15:55-16:05
ADAMTS-13 in aHUS: Laboratory Insight
Sanja STANKOVIC/Milica GAJOVIC, SERBIA
16:05-16:20
Genetic Testing in aHUS: Methodology and Test Interpretation
Beata LIPSKA-ZIĘTKIEWICZ, POLAND
16:20-16:35
aHUS and Complement: Clinical Perspective
Aleksandra ZUROWSKA, POLAND
Chairs: Andrija BOGDANOVIC, Milija MIJAJLOVIC
16:35-16:45
Neonatal Screening: What’s Next?
Emeline GERNEZ, FRANCE
16:45-16:55
Unmasking the Toxic Face of Nitric Oxide: An In-Depth Scientific and Laboratory Exploration
Guillaume GRZYCH, FRANCE
16:55-17:05
Diagnosing Cardiac Amyloidosis in Everyday Practice: How Can the Laboratory Help?
Arsen RISTIC, SERBIA
17:05-17:15
PNH: Insights into Laboratory Diagnosis and Targeted Therapy
Andrija BOGDANOVIC, SERBIA
17:15-17:25
Are Cerebrovascular Diseases Really Rare in Pregnancy and the Puerperium?
Milija MIJAJLOVIC, SERBIA
17:25-17:35
Vasculitis in Rare Disease Clinics: The Role of Laboratory Diagnostics
Maja STOJANOVIC, SERBIA
17:35-18:35
Discussion
18:35-18:45
Conclusions
INDUSTRY SESSIONS
DAY 1
THURSDAY, September 18th, 2025
12:00-12:30
Industry-Sponsored Symposium: Abbott
Revolutionizing Traumatic Brain Injury Care: The Power of Biomarkers
Speaker: Christos VAROUNIS, GREECE
12:30-12:50
Industry-Sponsored Symposium: Yunycom/Biomerieux
From Innovative Biomarkers to Reduced Head CT Scans
Speaker: Milan RACIC, SERBIA
13:50-14:15
Industry-Sponsored Symposium: AstraZeneca
Low Alkaline Phosphatase: A Key Indicator in the Diagnosis of Hypophosphatasia
Speaker: Khosrow ADELI, CANADA
INDUSTRY SESSIONS
DAY 2
FRIDAY, September 19th, 2025
11:40-12:20
Industry-Sponsored Symposium
Shining a New Light on ASCVD Risk Diagnostics: Lp(a) and the Future of Prevention
Speaker: Nebojsa TASIC, SERBIA
11:40-12:00
Industry-Sponsored Symposium: Roche
12:00-12:20
Industry-Sponsored Symposium: Novartis
Speaker: Sanja STANKOVIC, SERBIA
12:20-13:05
Industry-Sponsored Symposium: Snibe/BIOTEC
Paediatric Laboratory Medicine: Innovations and New Insights for Optimal Child Care
Speaker: Khosrow ADELI, CANADA
Innovations in Biomarker Nanotechnology: New Markers for Cardiovascular Risk Stratification, Tumour Markers, and Fertility
Speaker: Tanja ZDRAVKOVIC, SERBIA
13:05-13:30
Industry-Sponsored Symposium: Roche/ADOC
Digital Innovative Solutions as an Aid in Laboratory Work
Speaker: Milos LEKOVIC, SERBIA
15:15-15:35
Industry-Sponsored Symposium: AstraZeneca
Rare but Real: Shining a Light on aHUS
Speaker: Radomir NAUMOVIC, SERBIA